← All stocks

Sagimet Biosciences Inc.

SGMT No buying or selling
CIK 0001400118 #2909 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

5 insiders · 0 transactions
12.0×

David Happel holds 12.0 times base salary in stock. $7.59M of shares against $630.00K in salary for 2025.

Salary from the company's own proxy. The shares are what David Happel last reported holding, valued at $10.23, the price Series A Common Stock was last bought or sold at on the open market here, on 14 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Happel David
President & CEO
741,570
$7.59M
+16.0%
Rozek Elizabeth
Chief Legal & Admin. Officer
224,414
$2.30M
+39.8%
Martins Eduardo Bruno
Chief Medical Officer
147,296
$1.51M
+81.4%
Kemble George
Director
62,161
$636.08K
−47.6%
Chauche Thierry
Chief Financial Officer
59,688
$610.78K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 20 Jul 2023